Hurel Raises $9.2M in Series A Equity Round | GenomeWeb

NEW YORK (GenomeWeb News) – Bioanalytical tools company Hurel raised $9.2 million in a Series A private equity financing round, the North Brunswick, NJ-based company said today.

Proceeds from the round will go toward the commercial launch of Hurel's products, R&D work directed at its technologies and future products, and general corporate purposes, it said. Spring Mountain Capital led the round and was joined by undisclosed private investor entities.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers trace the deaths of a pair of newborn siblings to a mutation in their LIPT1 genes through whole-exome sequencing, Stat News reports.

In PNAS this week: system to track intron gains and losses, role of RUNX during mitosis, and more.

French officials release a report and move to strength safety measures for clinical trials, ScienceInsider reports.

Researchers find different molecular signatures in cancers from men as compared to those from women, the Wall Street Journal reports.